The topic of understanding nicotine and its relationship to health risks has become increasingly important in global public health discussions. The latest white paper released by the Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA), "Understanding Nicotine: Facts, Not Myths", calls for a rational and science-based approach to address tobacco harm and evaluate alternative product choices.
While the dangers of conventional tobacco use are widely recognized, there is still a significant gap in public understanding of nicotine itself. According to CAPHRA's research, over 60% of smokers mistakenly believe that nicotine is the direct cause of cancer. This misconception not only distorts risk perception but also limits open dialogue on tobacco alternatives and harm reduction strategies.
Scientific evidence makes it clear that the major health risks associated with smoking primarily result from the harmful substances produced by tobacco combustion, rather than from nicotine itself. As CAPHRA Executive Coordinator Nancy Loucas explains, “Nicotine is not the cause of cancer or cardiovascular disease. The real threat lies in the toxic byproducts of combustion.”
It is important to acknowledge that nicotine carries an addictive potential, a fact that remains at the center of public health discussions. However, CAPHRA's report highlights that when nicotine is delivered in non-combustible forms, its health risks are significantly lower. This is why various alternative nicotine products, such as electronic cigarettes, nicotine pouches, patches, and gum, are being discussed globally as part of science-based approaches to reducing smoking-related harm.
CAPHRA urges policymakers to rely on scientific evidence and risk-proportionate frameworks when shaping public health policies. Providing accurate information and access to reduced-risk alternatives where appropriate is seen as a key component of a balanced, health-oriented strategy. Transparent information, strict industry compliance, and responsible innovation also play an essential role in fostering a more informed public health environment.
As a brand committed to supporting responsible industry development, SP2S closely follows global public health trends and advocates for fact-based, science-driven discussions. We believe that promoting a clear, science-based understanding of nicotine, clarifying the root causes of tobacco-related health risks, and encouraging responsible innovation in alternative nicotine products are shared responsibilities for both the industry and society.
SP2S will continue to prioritize compliance, product quality, and transparent communication. We support the responsible development of science-based tobacco alternatives, empowering consumers to make informed and healthier choices while contributing to long-term global public health efforts.
Leave A Comment
Your email address will not be published.